Bisphosphonates in the adjuvant treatment of early breast cancer

Por Gnant, M
Publicado no Breast Cancer Res (2009)

The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis

Por Hadji, P., Coleman, R., Gnant, M., Green, J.
Publicado em 2012

Haemophilus parainfluenzae Liver Abscess after Successful Liver Transplantation

Por Friedl, J., Stift, A., Berlakovich, G. A., Taucher, S., Gnant, M., Steininger, R., Mühlbacher, F.
Publicado em 1998

Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma

Por Schmidinger, M, Wenzel, C, Locker, G J, Muehlbacher, F, Steininger, R, Gnant, M, Crevenna, R, Budinsky, A C
Publicado em 2001

Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy

Por Schindl, M., Függer, R., Götzinger, P., Längle, F., Zitt, M., Stättner, S., Kornprat, P., Sahora, K., Hlauschek, D., Gnant, M
Publicado no Br J Surg (2018)

Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancer.

Por Mader, R M, Steger, G G, Rizovski, B, Sieder, A E, Locker, G, Gnant, M F, Jakesz, R, Rainer, H
Publicado em 1994

Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer.

Por Fiegl, M., Tueni, C., Schenk, T., Jakesz, R., Gnant, M., Reiner, A., Rudas, M., Pirc-Danoewinata, H., Marosi, C., Huber, H.
Publicado em 1995

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Por Coates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J.
Publicado no Ann Oncol (2015)

P08.01 RESPONSE TO T-DM1 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES (BM)

Por Berghoff, A.S., Bartsch, R., Bergen, E., Rudas, M., Gnant, M., Dieckmann, K., Pinker, K., Zielinski, C.C., Steger, G.G., Preusser, M.
Publicado em 2014

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer...

Por Fitzal, F, Filipits, M, Rudas, M, Greil, R, Dietze, O, Samonigg, H, Lax, S, Herz, W, Dubsky, P, Bartsch, R, Kronenwett, R, Gnant, M
Publicado no Br J Cancer (2015)

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series

Por Zagouri, F, Sergentanis, T N, Koutoulidis, V, Sparber, C, Steger, G G, Dubsky, P, Zografos, G C, Psaltopoulou, T, Gnant, M, Dimopoulos, M-A, Bartsch, R
Publicado em 2013

Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer

Por Pfeiler, G, Königsberg, R, Hadji, P, Fitzal, F, Maroske, M, Dressel-Ban, G, Zellinger, J, Exner, R, Seifert, M, Singer, C, Gnant, M, Dubsky, P
Publicado em 2013

The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER(+), HER2(−) early breast cancer

Por Exner, R, Bago-Horvath, Z, Bartsch, R, Mittlboeck, M, Retèl, V P, Fitzal, F, Rudas, M, Singer, C, Pfeiler, G, Gnant, M, Jakesz, R, Dubsky, P
Publicado em 2014

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Por Curigliano, G, Burstein, H J, P. Winer, E, Gnant, M, Dubsky, P, Loibl, S, Colleoni, M, Regan, M M, Piccart-Gebhart, M, Senn, H -J, Thürlimann, B
Publicado no Ann Oncol (2019)

The sequential use of endocrine treatment for advanced breast cancer: where are we?

Por Barrios, C., Forbes, J. F., Jonat, W., Conte, P., Gradishar, W., Buzdar, A., Gelmon, K., Gnant, M., Bonneterre, J., Toi, M., Hudis, C., Robertson, J. F. R.
Publicado no Ann Oncol (2012)

A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

Por Schippinger, W, Jagoditsch, M, Sorré, C, Gnant, M, Steger, G, Hausmaninger, H, Mlineritsch, B, Schaberl-Moser, R, Mischinger, H J, Hofbauer, F, Holzberger, P, Mittlböck, M, Jakesz, R
Publicado em 2005

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the...

Por Gnant, M, Pfeiler, G, Stöger, H, Mlineritsch, B, Fitzal, F, Balic, M, Kwasny, W, Seifert, M, Stierer, M, Dubsky, P, Greil, R, Steger, G, Samonigg, H, Fesl, C, Jakesz, R
Publicado em 2013

Prognostic impact of breast cancer subtypes in elderly patients

Por Bergen, E. S., Tichy, C., Berghoff, A. S., Rudas, M., Dubsky, P., Bago-Horvath, Z., Mader, R. M., Exner, R., Gnant, M., Zielinski, C. C., Steger, G. G., Preusser, M., Bartsch, R.
Publicado no Breast Cancer Res Treat (2016)

Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value

Por Michlmayr, A, Bachleitner-Hofmann, T, Baumann, S, Marchetti-Deschmann, M, Rech-Weichselbraun, I, Burghuber, C, Pluschnig, U, Bartsch, R, Graf, A, Greil, R, Allmaier, G, Steger, G, Gnant, M, Bergmann, M, Oehler, R
Publicado em 2010

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer

Por Schippinger, W, Samonigg, H, Schaberl-Moser, R, Greil, R, Thödtmann, R, Tschmelitsch, J, Jagoditsch, M, Steger, G G, Jakesz, R, Herbst, F, Hofbauer, F, Rabl, H, Wohlmuth, P, Gnant, M, Thaler, J
Publicado em 2007